Ladder Bio is a therapeutics company developing Spiroligomer(TM) ladder-shaped peptide-like molecules--sequence-defined, structurally preorganized molecules designed to be orally available, cell permeable, and engage challenging biological targets with high affinity and selectivity. Ladder Bio's platform integrates rational design with modern discovery to create new treatment options for patients where conventional modalities fall short.
Leadership & Board
Current Number of Employees17
Current LinkedIn Followers671
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$6M
Total Amount Raised$6M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$6M
Latest Funding Amount$6M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Ladder Bio had 17 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
17Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Ladder Bio had 671 followers as of September 14, 2026. The number of followers increased by 5 (0.75%) week-over-week.
671Latest Followers Count
5(0.75%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.